Wishbone Medical

Executive Summary

Wishbone Medical is a privately held pediatric orthopedic medical device company headquartered in Warsaw, Indiana, founded in 2013. The company addresses the critical unmet need for anatomically appropriate implants designed specifically for children's growing skeletons. Its core innovation lies in delivering these implants and instruments as single-use, sterile-packed procedure kits, which streamline surgical workflows, reduce risk of cross-contamination, and improve overall surgical efficiency and safety. By focusing exclusively on pediatrics—a market often underserved by larger orthopedic device makers—Wishbone has carved out a niche position. The company's product portfolio covers a range of pediatric conditions, including fracture fixation, deformity correction, and limb reconstruction. Despite being private and without disclosed financials, Wishbone's mission-driven approach and differentiated product offering position it well for growth as pediatric orthopedic surgery becomes more specialized. The company benefits from strong clinical demand and a clear regulatory pathway in the US, with potential for expansion into international markets. Given the lack of publicly available revenue or valuation data, the conviction score is moderate, reflecting promising technology but limited visibility into commercial traction.

Upcoming Catalysts (preview)

• Q4 2026FDA 510(k) clearance for next-generation pediatric implant kit70% success
• H1 2027Strategic partnership with a major orthopedic distributor for US market expansion45% success
• Q2 2026Series B or C funding round to commercialize pipeline products60% success